(Q33877254)

29 July 2017

1 reference

title

Elucidating cell signaling mechanisms using antisense technology (English)

1 reference

29 July 2017

Koller E

1

1 reference

29 July 2017

Gaarde WA

series ordinal

2

1 reference

29 July 2017

Monia BP

series ordinal

3

1 reference

29 July 2017

1 April 2000

1 reference

Trends in Pharmacological Sciences

29 July 2017

1 reference

29 July 2017

21

1 reference

29 July 2017

142-148

1 reference

29 July 2017

4

1 reference

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Molecular mechanisms of action of antisense drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Novel mechanisms for antisense-mediated regulation of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Antisense approaches for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Direct Inhibition of Cyclooxygenase-1 and -2 by the Kinase Inhibitors SB 203580 and PD 98059

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Progress in antisense oligonucleotide therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

1 reference

7 January 2021

A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

A cytosine analog that confers enhanced potency to antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Treatment of vascular smooth muscle cells with antisense phosphorothioate oligodeoxynucleotides directed against p42 and p44 mitogen-activated protein kinases abolishes DNA synthesis in response to platelet-derived growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Evaluation of biological role of c-Jun N-terminal kinase using an antisense approach

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Distinct roles for the p110alpha and hVPS34 phosphatidylinositol 3'-kinases in vesicular trafficking, regulation of the actin cytoskeleton, and mitogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Interleukin-1 beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases, in human epithelial cells, by two independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Inhibition of adenylate cyclase activity by galanin in rat insulinoma cells is mediated by the G-protein Gi3.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901448-6

7 January 2021

10.1016/S0165-6147(00)01448-6

Identifiers

DOI

1 reference

release_pggd63tvsncgpor7hyini7blqu

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pggd63tvsncgpor7hyini7blqu

24 November 2022

mapped directly with Wikidata item

1 reference